{"id":"insulin-pre-treatment","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This approach involves administering insulin prior to a main treatment to enhance metabolic readiness and improve the body's ability to process glucose. By pre-conditioning tissues to respond to insulin signaling, the strategy aims to optimize metabolic state and potentially improve outcomes of subsequent therapeutic interventions, particularly in contexts where glucose metabolism is relevant.","oneSentence":"Insulin pre-treatment prepares the body to better utilize insulin by improving insulin sensitivity and glucose uptake before therapeutic intervention.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:33:24.652Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Investigational pre-treatment strategy (specific clinical indications not clearly established in public literature)"}]},"trialDetails":[{"nctId":"NCT07494084","phase":"PHASE4","title":"Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance","status":"NOT_YET_RECRUITING","sponsor":"Washington State University","startDate":"2026-05-01","conditions":"Shift Work Schedule, Circadian Rhythm, Insulin Resistance","enrollment":24},{"nctId":"NCT05713799","phase":"PHASE2","title":"Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":"Insulin Resistance, Obesity","enrollment":60},{"nctId":"NCT07293715","phase":"PHASE4","title":"Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2026-02-25","conditions":"Pregnancy, High Risk, Type 1 Diabetes","enrollment":44},{"nctId":"NCT07361874","phase":"NA","title":"IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-03-05","conditions":"Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS), Subclinical Cushing's","enrollment":75},{"nctId":"NCT07491133","phase":"NA","title":"Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2026-03","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT07490964","phase":"","title":"Polycystic Ovary Syndrome in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2026-04-01","conditions":"Type 1 Diabetes Mellitus, Polycystic Ovary Syndrome (PCOS)","enrollment":60},{"nctId":"NCT05610800","phase":"PHASE2","title":"Exenatide for Smoking Cessation and Prevention of Weight Gain","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-12-07","conditions":"Smoking Cessation, Weight Gain","enrollment":140},{"nctId":"NCT05663515","phase":"","title":"A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-09-30","conditions":"Pancreatic Cancer","enrollment":24000},{"nctId":"NCT07480993","phase":"","title":"Serum Betatrophin Levels in Normal-Weight and Overweight Adolescents With PCOS","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-01-15","conditions":"Polycystic Ovary Syndrome (PCOS), Betatrophin, Body Mass Index (BMI)","enrollment":90},{"nctId":"NCT07471854","phase":"NA","title":"Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05-01","conditions":"Acne Scars - Atrophic","enrollment":42},{"nctId":"NCT06671587","phase":"PHASE4","title":"iGlarLixi CGM Study in Chinese T2D Individuals After OADs","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-12-10","conditions":"Type 2 Diabetes (T2D)","enrollment":678},{"nctId":"NCT03878706","phase":"","title":"The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination","status":"RECRUITING","sponsor":"University of Athens","startDate":"2017-11-03","conditions":"Diabetes Mellitus, Type 2","enrollment":240},{"nctId":"NCT06686329","phase":"NA","title":"Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose","status":"RECRUITING","sponsor":"Jane Yardley","startDate":"2025-03-17","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT06334133","phase":"PHASE3","title":"Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes","status":"RECRUITING","sponsor":"vTv Therapeutics","startDate":"2024-06-14","conditions":"Diabetes Mellitus, Type 1","enrollment":150},{"nctId":"NCT07455643","phase":"NA","title":"Closed-loop Response to Unannounced Mixed and Carbohydrates-rich Breakfasts","status":"COMPLETED","sponsor":"University of Catania","startDate":"2025-04-20","conditions":"Type 1 Diabetes Mellitus","enrollment":20},{"nctId":"NCT06747468","phase":"PHASE3","title":"Avexitide for Treatment of Post-Bariatric Hypoglycemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amylyx Pharmaceuticals Inc.","startDate":"2025-04-29","conditions":"Post Bariatric Hypoglycemia","enrollment":75},{"nctId":"NCT07364045","phase":"NA","title":"Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS)","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2026-01-30","conditions":"Type 2 Diabetes","enrollment":104},{"nctId":"NCT03868592","phase":"NA","title":"Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2019-08-01","conditions":"Obesity, Morbid","enrollment":30},{"nctId":"NCT07427134","phase":"NA","title":"Pediatric Insulin Plan Calculator for T1DM Management","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2026-03-01","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus (T1DM), T1DM","enrollment":440},{"nctId":"NCT06449677","phase":"PHASE3","title":"Bionic Pancreas in CFRD","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2024-09-24","conditions":"Cystic Fibrosis-related Diabetes","enrollment":150},{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT05785832","phase":"NA","title":"A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2023-06-01","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":319},{"nctId":"NCT05279079","phase":"","title":"Markers in Acute Pancreatitis-1","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2023-01-25","conditions":"Acute Pancreatitis Drug-Induced","enrollment":175},{"nctId":"NCT05660083","phase":"PHASE2","title":"Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-12","conditions":"HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma","enrollment":36},{"nctId":"NCT03695315","phase":"","title":"Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2018-10-31","conditions":"Obstructive Sleep Apnea, Hypoxia, Insulin Resistance","enrollment":48},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT06185296","phase":"NA","title":"The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy","status":"RECRUITING","sponsor":"Aalborg University Hospital","startDate":"2025-11-15","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":51},{"nctId":"NCT06558422","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Pancreatic Clamp","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2027-01-01","conditions":"Insulin Resistance, Hyperinsulinemia, Metabolic Dysfunction Associated Steatotic Liver Disease","enrollment":36},{"nctId":"NCT06830486","phase":"","title":"Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2022-02-14","conditions":"Breast Cancer","enrollment":40},{"nctId":"NCT07224334","phase":"PHASE1","title":"Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.","status":"RECRUITING","sponsor":"David D'Alessio, M.D.","startDate":"2025-12-30","conditions":"Diabetes (DM)","enrollment":30},{"nctId":"NCT03956927","phase":"","title":"Feasibility of Simulation in Therapeutic Patient Education for Adult Diabetic Patients Using the Freestyle Libre® Device","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2019-05-24","conditions":"Insulin-Dependent Diabetes","enrollment":27},{"nctId":"NCT04614168","phase":"NA","title":"Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2021-07-26","conditions":"Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia, Hypoglycemia","enrollment":24},{"nctId":"NCT04232566","phase":"","title":"Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2022-02-20","conditions":"Obesity, Morbid, NASH - Nonalcoholic Steatohepatitis, Chronic Inflammation","enrollment":60},{"nctId":"NCT05427799","phase":"NA","title":"The Influence of Daily Honey Consumption on IR in Obese Women With IR","status":"COMPLETED","sponsor":"University of Jordan","startDate":"2022-03-01","conditions":"Insulin Resistance","enrollment":20},{"nctId":"NCT04341571","phase":"PHASE2","title":"Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2019-10-24","conditions":"PreDiabetes, Impaired Glucose Tolerance, Hyperglycemia","enrollment":30},{"nctId":"NCT06630585","phase":"PHASE3","title":"GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Bern","startDate":"2025-02-14","conditions":"Type 1 Diabetes (T1D)","enrollment":42},{"nctId":"NCT01239550","phase":"NA","title":"Insulin Detemir in Obesity Management","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2011-04","conditions":"Diabetes, Obesity","enrollment":240},{"nctId":"NCT05920694","phase":"NA","title":"Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-12-22","conditions":"Polycystic Ovary Syndrome, Obstructive Sleep Apnea","enrollment":20},{"nctId":"NCT06334068","phase":"NA","title":"SHOrt-term Glycemic Control for Reducing Post-SURGical Complications","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2024-05-08","conditions":"Diabetes, Uncontrolled Diabtetes","enrollment":53},{"nctId":"NCT07011147","phase":"NA","title":"Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02-01","conditions":"Type 1 Diabetes (T1D), Type 2 Diabetes, Diabetes, Autoimmune","enrollment":240},{"nctId":"NCT06915428","phase":"NA","title":"Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-02-01","conditions":"Preterm Birth Complication, Preterm Birth, Preterm Birth Recurrence","enrollment":1228},{"nctId":"NCT07240012","phase":"NA","title":"Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2025-12-01","conditions":"Diabete Type 1, Pregnancy Complications","enrollment":305},{"nctId":"NCT07336914","phase":"NA","title":"Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes","status":"RECRUITING","sponsor":"Khyber Medical University Peshawar","startDate":"2025-10-01","conditions":"Gestational Diabetes","enrollment":60},{"nctId":"NCT05724134","phase":"PHASE1","title":"Pancreatic Clamp in NAFLD","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-08-29","conditions":"Insulin Resistance, Prediabetic State, Hyperinsulinemia","enrollment":18},{"nctId":"NCT05000021","phase":"NA","title":"Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2022-06-27","conditions":"Type 1 Diabetes","enrollment":93},{"nctId":"NCT04825366","phase":"NA","title":"Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2021-08-03","conditions":"Type 1 Diabetes, Hypoglycemia Unawareness","enrollment":47},{"nctId":"NCT03746431","phase":"PHASE1","title":"A Phase 1 Study of [225Ac]-FPI-1434 Injection","status":"TERMINATED","sponsor":"Fusion Pharmaceuticals Inc.","startDate":"2019-01-17","conditions":"Advanced Solid Tumours, Endometrial Cancer, Cervical Cancer","enrollment":78},{"nctId":"NCT07317856","phase":"NA","title":"Efficacy of Microneedling With Hyaluronic Acid Injection for Gingival Augmentation in Thin Gingival Phenotype","status":"NOT_YET_RECRUITING","sponsor":"University of Baghdad","startDate":"2026-01","conditions":"Thin Gingival Biotype","enrollment":20},{"nctId":"NCT06609356","phase":"EARLY_PHASE1","title":"Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2025-07-03","conditions":"Type 1 Diabetes Mellitus, Glucokinase-Maturity Onset Diabetes of the Young (GCK-MODY), MODY2 Diabetes","enrollment":27},{"nctId":"NCT05153395","phase":"EARLY_PHASE1","title":"Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation","status":"SUSPENDED","sponsor":"University of Missouri-Columbia","startDate":"2021-12-01","conditions":"Healthy, Vasodilation, Insulin Resistance","enrollment":65},{"nctId":"NCT07286019","phase":"NA","title":"Effects of Long Duration Cycling in People With Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitat de Girona","startDate":"2025-11-22","conditions":"Type 1 Diabetes (T1D)","enrollment":29},{"nctId":"NCT04770532","phase":"PHASE3","title":"A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-03-05","conditions":"Diabetes Mellitus, Type 2","enrollment":526},{"nctId":"NCT04460885","phase":"PHASE3","title":"A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-11-25","conditions":"Diabetes Mellitus, Type 2","enrollment":984},{"nctId":"NCT06545721","phase":"NA","title":"Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-08-13","conditions":"Polycystic Ovary Syndrome","enrollment":425},{"nctId":"NCT02546401","phase":"PHASE3","title":"Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2015-09","conditions":"Diabetes Type 1","enrollment":22},{"nctId":"NCT06776094","phase":"NA","title":"Physical Activity and Insulin Sensitivity Dynamics","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-05-05","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT00803179","phase":"PHASE1","title":"Growth Hormone Therapy for Wasting in Cystic Fibrosis","status":"TERMINATED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-11","conditions":"Cystic Fibrosis","enrollment":5},{"nctId":"NCT06488469","phase":"NA","title":"Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-07-01","conditions":"Type 1 Diabetes","enrollment":50},{"nctId":"NCT07252752","phase":"NA","title":"Dopamine and Insulin in Psychosis","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Vienna","startDate":"2026-01-01","conditions":"First Episode Psychosis (FEP)","enrollment":46},{"nctId":"NCT05206877","phase":"PHASE1","title":"Topical Insulin for Glaucoma","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-04-01","conditions":"Glaucoma","enrollment":52},{"nctId":"NCT07239700","phase":"NA","title":"Buzzy and TickleFlex in Reducing Insulin Injection Pain and Fear","status":"ENROLLING_BY_INVITATION","sponsor":"Hakkari Universitesi","startDate":"2025-06-06","conditions":"Diabete Type 1, Diabetes in Children","enrollment":90},{"nctId":"NCT05687500","phase":"PHASE2","title":"Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-20","conditions":"Transient; Hypoglycemia, Neonatal, Preterm, Glibenclamide Adverse Reaction","enrollment":35},{"nctId":"NCT07234500","phase":"NA","title":"Evaluation of a Mobile Application Designed to Support Type 1 Diabetic Patients in Adjusting Their Insulin Doses.","status":"ENROLLING_BY_INVITATION","sponsor":"University of Baghdad","startDate":"2025-09-01","conditions":"Type One Diabetes Mellitus","enrollment":50},{"nctId":"NCT04124302","phase":"PHASE4","title":"The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2019-10-01","conditions":"Diabetes Mellitus, Type 1","enrollment":76},{"nctId":"NCT07045298","phase":"NA","title":"CGM Use in Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-04","conditions":"Heart Failure, Diabetes Mellitus","enrollment":140},{"nctId":"NCT05734313","phase":"NA","title":"Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2023-03-31","conditions":"Diabetes, Type 1 Diabetes","enrollment":94},{"nctId":"NCT07006480","phase":"NA","title":"Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-10-01","conditions":"Diabetes Mellitus","enrollment":150},{"nctId":"NCT06090864","phase":"PHASE1, PHASE2","title":"ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2024-04-25","conditions":"Hodgkin Lymphoma, Relapse, Refractory","enrollment":31},{"nctId":"NCT06752928","phase":"NA","title":"A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-05-12","conditions":"Type 1 Diabetes","enrollment":100},{"nctId":"NCT06820281","phase":"PHASE2","title":"Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Garvan Institute of Medical Research","startDate":"2025-12-01","conditions":"Type 1 Diabetes Mellitus","enrollment":44},{"nctId":"NCT06798402","phase":"PHASE2","title":"Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate","status":"RECRUITING","sponsor":"Al-Mustafa University College","startDate":"2025-02-07","conditions":"Cutaneous Leishmaniasis","enrollment":80},{"nctId":"NCT06974201","phase":"NA","title":"The Effect of Diabetes M Application Use Versus Conventional Bolus Calculation in Patients With Type 1 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Sofia","startDate":"2025-04-15","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT06797544","phase":"PHASE2","title":"Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis","status":"RECRUITING","sponsor":"Hayder Adnan Fawzi","startDate":"2025-02-09","conditions":"Cutaneous Leishmaniasis","enrollment":40},{"nctId":"NCT06420518","phase":"","title":"Accuracy of a Continuous Ketone Monitoring (CKM) System in Individuals With Type 1 Diabetes on Insulin Pump Therapy.","status":"COMPLETED","sponsor":"McGill University","startDate":"2024-04-30","conditions":"type1diabetes","enrollment":16},{"nctId":"NCT07180446","phase":"NA","title":"Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders","status":"NOT_YET_RECRUITING","sponsor":"Texas Christian University","startDate":"2025-09-18","conditions":"Obesity &Amp; Overweight","enrollment":25},{"nctId":"NCT04198857","phase":"NA","title":"Development and Testing of a Mobile Health Application for Management of Gestational Diabetes","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2021-10-18","conditions":"Diabetes, Gestational, Telemedicine","enrollment":220},{"nctId":"NCT03608163","phase":"PHASE4","title":"Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)","status":"TERMINATED","sponsor":"Albert Einstein College of Medicine","startDate":"2019-01-08","conditions":"Diabetes Mellitus, Type 1, Hypoglycemia, Hypoglycemia Unawareness","enrollment":4},{"nctId":"NCT05614089","phase":"PHASE4","title":"Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings","status":"COMPLETED","sponsor":"Jing Luo","startDate":"2023-03-15","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes","enrollment":400},{"nctId":"NCT07056712","phase":"NA","title":"Effect of Fenugreek Seed Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion","status":"NOT_YET_RECRUITING","sponsor":"University of Guadalajara","startDate":"2025-09-15","conditions":"Metabolic Syndrome","enrollment":28},{"nctId":"NCT05988632","phase":"PHASE1, PHASE2","title":"Intranasal Insulin for Treatment of Alcohol Use Disorder","status":"RECRUITING","sponsor":"Brown University","startDate":"2025-02-25","conditions":"Alcohol Use Disorder","enrollment":40},{"nctId":"NCT07133854","phase":"NA","title":"How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver","status":"NOT_YET_RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2026-09","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Steato-Hepatitis (NASH), Type 1 Diabetes Mellitus","enrollment":32},{"nctId":"NCT07066891","phase":"NA","title":"Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-07-15","conditions":"Diabetes Mellitus, Type 2 Diabetes","enrollment":400},{"nctId":"NCT03890432","phase":"NA","title":"GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU)","status":"COMPLETED","sponsor":"HEIDEGGER CP","startDate":"2023-01-10","conditions":"Critical Illness, Energy Supply; Deficiency, Severe, Protein Deficiency","enrollment":213},{"nctId":"NCT06968286","phase":"NA","title":"The Effect of Locally Dilvered Ciprofloxacine Loaded Injectable Platelet-rich Fibrin as an Adjunct to Non-surgical Periodontal Therapy on the Gingival Crevicular Level of Interleukin 6","status":"COMPLETED","sponsor":"Suez Canal University","startDate":"2025-01-01","conditions":"Periodontitis Stage II","enrollment":60},{"nctId":"NCT06167499","phase":"NA","title":"Therapeutic Education Consultations With Diabetic Patients Treated With Intensified Insulin Therapy","status":"TERMINATED","sponsor":"Hopital Nord Franche-Comte","startDate":"2024-02-09","conditions":"Diabete Mellitus, Insulin Dependent Diabetes","enrollment":7},{"nctId":"NCT06025513","phase":"NA","title":"De-tensioning Patch, in Subjects With Type 1 Diabetes and Lipohypertrophy","status":"COMPLETED","sponsor":"Neodyne Biosciences, Inc.","startDate":"2024-02-16","conditions":"Insulin Resistance, Lipohypertrophy","enrollment":29},{"nctId":"NCT07074379","phase":"NA","title":"Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-07-21","conditions":"Painless Chronic Pancreatitis","enrollment":126},{"nctId":"NCT03298295","phase":"NA","title":"Inflammatory Response to CSII Catheters in a Tummy Tuck Model","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2018-02-01","conditions":"Diabetes Mellitus","enrollment":20},{"nctId":"NCT06794658","phase":"NA","title":"EFFICACY OF REMOTE MONITORING OF PATIENTS WITH DIABETES UNDER INSULIN TREATMENT, BY USING Caaring SOFTWARE","status":"RECRUITING","sponsor":"Persei Vivarium","startDate":"2024-12-11","conditions":"Diabetes Mellitus","enrollment":200},{"nctId":"NCT04300790","phase":"PHASE2","title":"Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients","status":"COMPLETED","sponsor":"MedSIR","startDate":"2020-10-23","conditions":"Breast Cancer","enrollment":69},{"nctId":"NCT05286892","phase":"NA","title":"Diabetes Learning in Virtual Environments Just in Time for Community Reentry","status":"RECRUITING","sponsor":"Louise Reagan","startDate":"2023-04-30","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":128},{"nctId":"NCT07087496","phase":"NA","title":"Mobile Augmented Reality Learning On Insulin Administration Knowledge And Skills Of Patients","status":"COMPLETED","sponsor":"Izmir Bakircay University","startDate":"2023-11-01","conditions":"Diabete Type 2, Augmented Reality, Patient Education","enrollment":100},{"nctId":"NCT05718089","phase":"NA","title":"Precision Exercise Therapeutics (PET-pilot)","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2023-03-01","conditions":"Overweight, Healthy","enrollment":24},{"nctId":"NCT07067515","phase":"PHASE1, PHASE2","title":"Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival Hyperpigmentation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez Canal University","startDate":"2024-01-03","conditions":"Hyperpigmentation, Gingival Hyperpigmentaion","enrollment":30},{"nctId":"NCT00922402","phase":"NA","title":"Heart & Diabetes - Feasibility Study","status":"WITHDRAWN","sponsor":"Medtronic Cardiac Rhythm and Heart Failure","startDate":"2009-06","conditions":"Acute Heart Failure","enrollment":""},{"nctId":"NCT07049601","phase":"NA","title":"THE Effect of Tight Glycemic Control on Microvascular Complications in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-05-11","conditions":"Diabetes Mellitus","enrollment":80},{"nctId":"NCT05922033","phase":"PHASE4","title":"Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2023-10-19","conditions":"Gestational Diabetes Mellitus, Pregnancy in Diabetic, Pregnancy, High Risk","enrollment":56},{"nctId":"NCT07034482","phase":"","title":"Efficacy and Safety of Intralesional 5-Fluorouracil and Triamcinolone Acetonide in Keloids and Hypertrophic Scars","status":"COMPLETED","sponsor":"Maharajgunj Medical Campus","startDate":"2020-09-01","conditions":"Keloids","enrollment":41},{"nctId":"NCT06412497","phase":"PHASE2","title":"MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-06-05","conditions":"Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia","enrollment":60},{"nctId":"NCT06668714","phase":"NA","title":"Does Co-administration of Lactate Affect Postprandial Nutrient Absorption and Fat Disposition?","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-08-22","conditions":"Pre Diabetes, Metabolic Syndrome","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"insulin pre-treatment","genericName":"insulin pre-treatment","companyName":"University of Minnesota","companyId":"university-of-minnesota","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin pre-treatment prepares the body to better utilize insulin by improving insulin sensitivity and glucose uptake before therapeutic intervention. Used for Investigational pre-treatment strategy (specific clinical indications not clearly established in public literature).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}